Involvement of ICAM5 in Carcinostasis Effects on LUAD Based on the ROS1-Related Prognostic Model
We constructed a 17-gene prognostic risk model and found differences in immune-related cells, biological processes, and prognosis among patients in different risk groups based on the correlation between <i>ROS1</i> and immunity. Personalized therapy may play an essential role in treatment. We further investigated the role of <i>ICAM5</i> in inhibiting the malignant bioactivity of LUAD cells.
Authors
- Haotian Zheng (ORCID: https://orcid.org/0009-0006-5258-7685)
- Hongchang Shen
- Zhaofei Pang
- Qingtao Song
- Baoliang Liu (ORCID: https://orcid.org/0000-0001-6414-2292)
- Jiajun Du (ORCID: https://orcid.org/0000-0003-2406-9435)
- Gemu Huang
- Guoyuan Ma
- Guanghui Wang
Institutions
- Shandong Provincial Hospital (CN)
- Dian Diagnostics (China) (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/jir.s475088
- Citations
- 2
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.57